TCR gene-rearranged, extranodal NK/T-cell lymphoma, nasal type, presenting as gyrate patches

Journal of Dermatology

Volumn 29, Issue 10, 2002, Pages 648-652

  Hwang, Dong Kyu ^a   Kwon, Hyeok Man ^a   Park, Jin Woo ^a   Yu, Hee Joon ^a   Park, Yong Wook ^a  

^a Hanyang University   (South Korea)

Author keywords

Gyrate skin eruption; Nasal and nasal type NK T cell lymphoma

Indexed keywords

CD2 ANTIGEN; CD3 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; T LYMPHOCYTE RECEPTOR;

ADULT; ARTICLE; CASE REPORT; EPSTEIN BARR VIRUS; ERYTHEMA; FEMALE; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MYCOSIS FUNGOIDES; NATURAL KILLER CELL; NONHUMAN; NOSE; PAPULE; RASH; SKIN INFILTRATE; SKIN NODULE; SKIN ULCER; T CELL LYMPHOMA; TUMOR CLASSIFICATION;

EID: 0036807468     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2002.tb00196.x     Document Type: Article

References (14)

1. Bastian BC: Primary cutaneous natural killer/T-cell lymphoma, Arch Dermatol, 134: 109-111, 1998.
2. Yoon TY, Lee HT, Chang SH: Nasal-type T/natural killer cell angiocentric lymphoma, Epstein-Barr virus-associated, and showing clonal T-cell receptor γ gene rearrangement, Br J Dermatol, 140: 505-508, 1999.
3. Radonich MA, Lazova R, Bolognia J: Cutaneous natural killer/T-cell lymphoma, J Am Acad Dermatol, 46: 451-456, 2002.
4. Chan JK, Sin VC, Wong KF, et al: Nonnasal lymphoma expressing the natural killer cell marker CD56: A clinicopathologic study of 49 cases of an uncommon aggressive neoplasm, Blood, 89: 4501-4513, 1997.
5. Wechsler J, Willemze R, Brule A, et al: Differences in Epstein-Barr virus expression between primary and secondary cutaneous angiocentric lymphomas, Arch Dermatol, 134: 479-484, 1998.
6. Mraz-Gernhard S, Natkunam Y, Hoppe RT, LeBoit P, Kohler S, Kin YH: Natural Killer/natural killer-like T-cell lymphoma, CD56+, presenting in the skin: An increasingly recognized entity with an aggressive course, J Clin Oncol, 19: 2179-2188, 2001.
7. Park SJ, Kim SH, Lee ES: A case of nasal-type T/NK-cell lymphoma resembling cellulites, Kor J Dermatol, 39: 914-917, 2001.
8. Jaffe ES, Chan JKC, Su IJ, et al: Report of the workshop on nasal and related extranodal angio-centric T/natural killer cell lymphomas: Definitions, differential diagnosis, and epidemiology, Am J Surg Pathol, 20: 103-111, 1996.
9. Jaffe ES: Classification of natural killer (NK) cell and NK-like T-cell malignancies, Blood, 87: 1207-1210, 1996.
10. Kato N, Yasukawa K, Onozuka T, Kikuta H: Nasal and nasal-type T/NK-cell lymphoma with cutaneous involvement, J Am Acad Dermatol, 40: 850-856, 1999.
11. Xu ZG, Iwatsuki K, Oyama N, et al: The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas, Br J Cancer, 84: 920-925, 2001.
12. Miyamoto T, Yoshino T, Takehisa T, Hagari Y, Mihara M: Cutaneous presentation of nasal/nasal type T/NK cell lymphoma: Clinic opathological findings of four cases, Br J Dermatol, 139: 481-487, 1998.
13. Aviles A, Diaz NR, Neri N, Cleto S, Talavera A: Angiocentric nasal T/natural killer cell lymphoma: A single center study of prognostic factors in 108 patients, Clin Lab Haem, 22: 215-220, 2000.
14. Chang SE, Yoon GS, Huh J, et al: Primary nasal CD56+ NK/T-cell lymphoma with cutaneous involvement, Kor J Dermatol, 38: 713-720, 2000.